Faculty Opinions recommendation of Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.
Philippe Van Trappen(Karolinska University Hospital)
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
October 1, 2008
Cited by 0
Related Papers
Molecular profiling of cervical cancer progression
|British Journal of Cancer|2007|67